Literature DB >> 17124013

Observational studies of drug safety--aprotinin and the absence of transparency.

William R Hiatt1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17124013     DOI: 10.1056/NEJMp068252

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  The value of observational cohort studies for cancer drugs.

Authors:  David R Spigel
Journal:  Biotechnol Healthc       Date:  2010

2.  Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model.

Authors:  Neil A Goldenberg; Alex C Spyropoulos; Jonathan L Halperin; Craig M Kessler; Sam Schulman; Alexander G G Turpie; Allan M Skene; Neal R Cutler; William R Hiatt
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

3.  Medicine. Moving toward transparency of clinical trials.

Authors:  Deborah A Zarin; Tony Tse
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

Review 4.  Is there still a role for aprotinin in cardiac surgery?

Authors:  Neel R Sodha; Munir Boodhwani; Frank W Sellke
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?

Authors:  Russell G Thornton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

6.  Safety of low-dose aprotinin in coronary artery bypass graft surgery: a single-centre investigation in 2,436 patients in Germany.

Authors:  Mario Kluth; Jan U Lueth; Armin Zittermann; Markus Lanzenstiel; Reiner Koerfer; Kazuo Inoue
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 7.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

8.  Acute renal failure following lung transplantation: risk factors, mortality, and long-term consequences.

Authors:  Frédéric Jacques; Ismail El-Hamamsy; Annik Fortier; Simon Maltais; Louis P Perrault; Moishe Liberman; Nicolas Noiseux; Pasquale Ferraro
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

9.  Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery.

Authors:  Sean M Berenholtz; Julius Cuong Pham; Elizabeth Garrett-Mayer; Christine W Atchison; John P Kostuik; David B Cohen; Shantanu Nundy; Todd Dorman; Paul M Ness; Michael J Klag; Peter J Pronovost; Khaled M Kebaish
Journal:  Spine (Phila Pa 1976)       Date:  2009-09-01       Impact factor: 3.468

10.  Use and outcomes of antifibrinolytic therapy in patients undergoing cardiothoracic surgery at 20 academic medical centers in the United States.

Authors:  Karl Matuszewski; Robert Schoenhaus; Mary Ellen Bonk; James Lane; Michael Oinonen
Journal:  P T       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.